Home Category Region Publishers About Us Contact Us
Japanese Korean Chinese
Home > Market Research Report > Medical Device > Nuclear Medical > Global Markets for Nuclear Medicine Systems 2009
Category
Medical Device (4398)
Cardiovascular Device (252)
Catheter Equipment (209)
CT and MRI and X ray (146)
Dental Equipment (177)
Disposable Medical Device (83)
Endoscopy Equipment (114)
Healthcare IT (310)
In Vitro Diagnostics Equipment (435)
Medical Imaging (425)
Molecular Imaging/Agents (29)
Nuclear Medical (76)
Ophthalmic Equipment (105)
Orthopedic (343)
Patient Monitoring (384)
Ultra Sound (50)
Wound Care (120)
Market Research Report

Global Markets for Nuclear Medicine Systems 2009

Published by Millennium Research Group
Published October, 2009 Product code 103267
Content info  
Price
US $ 4197 Web Access and PDF Download (Single user license)
US $ 6300 Web Access and PDF Download (Corporate use license)


Global Markets for Nuclear Medicine Systems 2009 published by Millennium Research Group in October, 2009. This report price starts from US $ 4197.

Introduction

Abstract

The global market for nuclear medicine systems is composed of sales of positron emission tomography/computed tomography (PET/CT) and single photon emission computed tomography (SPECT) systems. In 2008, revenues in this market declined sharply due to the onset of the global economic crisis as well as reduced demand in the US, where the market is mature and existing systems are not being used to capacity. Revenues in all three regions in this market will continue to suffer in 2009 because of the economic crisis, government restrictions in China, market maturity in western countries, and concerns over low reimbursement rates. As the crisis recedes in 2010, however, the market will stabilize, driven by replacement sales, increased PET/CT procedure volumes- encouraged by benefits of PET/CT scanning in oncology- and adoption of more expensive hybrid SPECT/CT systems- favored by facilities because of their richer feature set. Despite this upturn, the global market for nuclear medicine systems will experience a slight overall decrease over the forecast period.

Table of Contents

LIST OF EXHIBITS

EXECUTIVE SUMMARY

METHODOLOGY

1.0 GLOBAL NUCLEAR MEDICINE SYSTEM MARKET

  • 1.1 Market Overview
  • 1.2 Market Analysis
    • 1.2.1 Economic Assumptions for the Forecast Period
    • 1.2.2 Market Definition
    • 1.2.3 Market Forecast
      • 1.2.3.1 US Nuclear Medicine System Market
      • 1.2.3.2 European Nuclear Medicine System Market
      • 1.2.3.3 Chinese Nuclear Medicine System Market
    • 1.2.4 Market Drivers and Limiters
      • 1.2.4.1 Market Drivers
      • 1.2.4.2 Market Limiters
  • 1.3 Competitive Analysis
    • 1.3.1 Market Shares

2.0 US NUCLEAR MEDICINE SYSTEM MARKET

  • 2.1 Market Overview
  • 2.2 Market Analysis
    • 2.2.1 Market Definition
    • 2.2.2 Procedures
    • 2.2.3 Market Forecast
      • 2.2.3.1 PET/CT System Market
      • 2.2.3.2 SPECT System Market
        • Stand-Alone SPECT System Market
        • Hybrid SPECT/CT System Market
        • Dedicated Cardiac Camera Market
      • 2.2.3.3 Installed Base
    • 2.2.4 Market Drivers and Limiters
      • 2.2.4.1 Market Drivers
      • 2.2.4.2 Market Li+miters
  • 2.3 Competitive Analysis
    • 2.3.1 Market Shares
    • 2.3.2 Competitor Discussions (in Alphabetical Order)
      • Digirad
      • GE Healthcare
      • Philips Healthcare
      • Siemens Healthcare
      • Other

3.0 EUROPEAN NUCLEAR MEDICINE SYSTEM MARKET

  • 3.1 Market Overview
  • 3.2 Market Analysis
    • 3.2.1 Market Definition
    • 3.2.2 Market Forecast
      • 3.2.2.1 PET/CT System Market
      • 3.2.2.2 SPECT System Market
        • Hybrid SPECT/CT System Market
        • Stand-Alone SPECT System Market
    • 3.2.3 Market Drivers and Limiters
      • 3.2.3.1 Market Drivers
      • 3.2.3.2 Market Limiters
  • 3.3 Competitive Analysis
    • 3.3.1 Market Shares
    • 3.3.2 Competitor Discussions (in Alphabetical Order)
      • GE Healthcare
      • Philips Healthcare
      • Siemens Healthcare

4.0 CHINESE NUCLEAR MEDICINE SYSTEM MARKET

  • 4.1 Market Overview
  • 4.2 Market Analysis
    • 4.2.1 Market Definition
    • 4.2.2 Market Forecast
      • 4.2.2.1 PET/CT System Market
      • 4.2.2.2 SPECT System Market
        • Stand-Alone SPECT System Market
        • Hybrid SPECT/CT System Market
      • 4.2.2.3 Installed Base
    • 4.2.3 Market Drivers and Limiters
      • 4.2.3.1 Market Drivers
      • 4.2.3.2 Market Limiters
  • 4.3 Competitive Analysis
    • 4.3.1 Market Shares
    • 4.3.2 Competitor Discussions (in Alphabetical Order)
      • GE Healthcare
      • Philips Healthcare
      • Siemens Healthcare

APPENDIX A: MRG ACRONYMS AND INITIALISMS

APPENDIX B: SUPPLEMENTAL EXHIBITS

List of Exhibits

EXECUTIVE SUMMARY

  • Exhibit 1: Nuclear Medicine System Market, Global (US$), 2007- 2013
  • Exhibit 2: Nuclear Medicine System Market, by Segment, US (US$), 2007- 2013
  • Exhibit 3: Nuclear Medicine System Market, by Country, Europe (US$), 2007- 2013
  • Exhibit 4: Nuclear Medicine System Market, by Segment, China (US$), 2007- 2013
  • Exhibit 5: Leading Competitors in the Nuclear Medicine System Market, Global, 2008

METHODOLOGY

  • Exhibit 6: Currency Exchange Rates, 2008
  • CHAPTER 1: GLOBAL NUCLEAR MEDICINE SYSTEM MARKET
  • Exhibit 7: Nuclear Medicine System Market, Global (US$), 2007- 2013
  • Exhibit 8: Nuclear Medicine System Market Segmentation, by Country, Global, 2007- 2013
  • Exhibit 9: Nuclear Medicine System Market, by Country, Global (US$), 2007- 2013
  • Exhibit 10: Drivers and Limiters of the Nuclear Medicine System Market, Global
  • Exhibit 11: Leading Competitors in the Nuclear Medicine System Market, by Country, as a % of Total, Global, 2008

Chapter 2: US NUCLEAR MEDICINE SYSTEM MARKET

  • Exhibit 12: Nuclear Medicine System Market, US (US$), 2007- 2013
  • Exhibit 13: Nuclear Medicine Procedures, by Segment, US, 2007- 2013
  • Exhibit 14: Nuclear Medicine System Market, by Segment, US (US$), 2007- 2013
  • Exhibit 15: PET/CT System Market, US (US$), 2007- 2013
  • Exhibit 16: SPECT System Market, by Segment, US (US$), 2007- 2013
  • Exhibit 17: SPECT System Market Growth, by Segment, US, 2008- 2013
  • Exhibit 18: Nuclear Medicine System Installed Base, by Segment, US, 2007- 2013
  • Exhibit 19: Drivers and Limiters of the Nuclear Medicine System Market, US
  • Exhibit 20: Leading Competitors in the Nuclear Medicine System Market, by Segment, as a % of Total, US, 2008

Chapter 3: EUROPEAN NUCLEAR MEDICINE SYSTEM MARKET

  • Exhibit 21: Nuclear Medicine System Market, Europe (US$), 2007- 2013
  • Exhibit 22: Nuclear Medicine System Market, by Segment and Country, Europe (US$), 2007- 2013
  • Exhibit 23: Nuclear Medicine System Market, by Segment and Country, Europe (- and -), 2007- 2013
  • Exhibit 24: Nuclear Medicine System Market Growth, by Segment and Country, Europe, 2008- 2013
  • Exhibit 25: PET/CT System Market, by Country, Europe (US$), 2007- 2013
  • Exhibit 26: PET/CT System Market, by Country, Europe (- and -), 2007- 2013
  • Exhibit 27: PET/CT System Market Growth, by Country, Europe, 2008- 2013
  • Exhibit 28: SPECT System Market, by Country, Europe (US$), 2007- 2013
  • Exhibit 29: SPECT System Market, by Country, Europe (- and -), 2007- 2013
  • Exhibit 30: SPECT System Market Growth, by Country, Europe, 2008- 2013
  • Exhibit 31: Hybrid SPECT/CT System Market, by Country, Europe (US$), 2007- 2013
  • Exhibit 32: Hybrid SPECT/CT System Market, by Country, Europe (- and -), 2007- 2013
  • Exhibit 33: Hybrid SPECT/CT System Market Growth, by Country, Europe, 2008- 2013
  • Exhibit 34: Stand-Alone SPECT System Market, by Country, Europe (US$), 2007- 2013
  • Exhibit 35: Stand-Alone SPECT System Market, by Country, Europe (- and -), 2007- 2013
  • Exhibit 36: Stand-Alone SPECT System Market Growth, by Country, Europe, 2008- 2013
  • Exhibit 37: Drivers and Limiters of the Nuclear Medicine System Market, Europe
  • Exhibit 38: Leading Competitors in the Nuclear Medicine System Market, by Country, as a % of Total, Europe, 2008
  • Exhibit 39: Leading Competitors in the PET/CT System Market, by Country, as a % of Total, Europe, 2008
  • Exhibit 40: Leading Competitors in the SPECT System Market, by Country, as a % of Total, Europe, 2008

Chapter 4: CHINESE NUCLEAR MEDICINE SYSTEM MARKET

  • Exhibit 41: Nuclear Medicine System Market, China (US$), 2007- 2013
  • Exhibit 42: Nuclear Medicine System Market, by Segment, China (US$ and CNY), 2007- 2013
  • Exhibit 43: PET/CT System Market, China (US$ and CNY), 2007- 2013
  • Exhibit 44: SPECT System Market, by Segment, China (US$), 2007- 2013
  • Exhibit 45: SPECT System Market, by Segment, China (CNY), 2007- 2013
  • Exhibit 46: SPECT System Market Growth, by Segment, China, 2008- 2013
  • Exhibit 47: Nuclear Medicine System Installed Base, by Segment, China, 2007- 2013
  • Exhibit 48: Drivers and Limiters of the Nuclear Medicine System Market, China
  • Exhibit 49: Leading Competitors in the Nuclear Medicine System Market, as a % of Total, China, 2008

APPENDIX B: SUPPLEMENTAL EXHIBITS

  • Exhibit 50: Nuclear Medicine System Market, Global (US$), 2007- 2013 (Detailed Format)
  • Exhibit 51: Nuclear Medicine System Market, by Segment, US (US$), 2007- 2013 (Detailed Format)
  • Exhibit 52: Nuclear Medicine System Market, by Country, Europe (US$), 2007- 2013 (Detailed Format)
  • Exhibit 53: Nuclear Medicine System Market, by Segment, China (US$), 2007- 2013 (Detailed Format)
Back to Top